{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:47:53Z","timestamp":1789501673691,"version":"build-2803163510"},"reference-count":53,"publisher":"Impact Journals, LLC","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,4,4]]},"DOI":"10.18632\/oncotarget.15152","type":"journal-article","created":{"date-parts":[[2017,2,8]],"date-time":"2017-02-08T17:56:15Z","timestamp":1486576575000},"page":"22649-22661","source":"Crossref","is-referenced-by-count":47,"title":["HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma"],"prefix":"10.18632","volume":"8","author":[{"given":"Laura","family":"Pellegrini","sequence":"first","affiliation":[{"name":"University of Hawai'i Cancer Center, University of Hawai'i at Manoa, Honolulu, HI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaming","family":"Xue","sequence":"additional","affiliation":[{"name":"University of Hawai'i Cancer Center, University of Hawai'i at Manoa, Honolulu, HI, USA"},{"name":"Leeward Community College, Mathematics and Sciences Division, University of Hawai'i System, Pearl City, HI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Larson","sequence":"additional","affiliation":[{"name":"University of Hawai'i Cancer Center, University of Hawai'i at Manoa, Honolulu, HI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Pastorino","sequence":"additional","affiliation":[{"name":"University of Hawai'i Cancer Center, University of Hawai'i at Manoa, Honolulu, HI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Jube","sequence":"additional","affiliation":[{"name":"University of Hawai'i at Manoa, Department of Cell and Molecular Biology, John A. Burns School of Medicine, Honolulu, HI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly H.","family":"Forest","sequence":"additional","affiliation":[{"name":"Leeward Community College, Mathematics and Sciences Division, University of Hawai'i System, Pearl City, HI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyana Salim","family":"Saad-Jube","sequence":"additional","affiliation":[{"name":"University of Hawai'i at Manoa, Myron B. Thompson School of Social Work, Office of Public Health and Center on Aging, Honolulu, HI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Napolitano","sequence":"additional","affiliation":[{"name":"University of Hawai'i Cancer Center, University of Hawai'i at Manoa, Honolulu, HI, USA"},{"name":"University of Hawai'i at Manoa, Department of Molecular Biosciences and Bioengineering, Honolulu, HI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Pagano","sequence":"additional","affiliation":[{"name":"University of Hawai'i Cancer Center, University of Hawai'i at Manoa, Honolulu, HI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal S.","family":"Negi","sequence":"additional","affiliation":[{"name":"University of Hawai'i at Manoa, Department of Molecular Biosciences and Bioengineering, Honolulu, HI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco E.","family":"Bianchi","sequence":"additional","affiliation":[{"name":"San Raffaele University and Research Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Morris","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Queen's Medical Center, Honolulu, HI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey I.","family":"Pass","sequence":"additional","affiliation":[{"name":"New York University School of Medicine, Department of Cardiothoracic Surgery, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Gaudino","sequence":"additional","affiliation":[{"name":"University of Hawai'i Cancer Center, University of Hawai'i at Manoa, Honolulu, HI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Carbone","sequence":"additional","affiliation":[{"name":"University of Hawai'i Cancer Center, University of Hawai'i at Manoa, Honolulu, HI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haining","family":"Yang","sequence":"additional","affiliation":[{"name":"University of Hawai'i Cancer Center, University of Hawai'i at Manoa, Honolulu, HI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,2,7]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/jcp.22724","article-title":"Malignant mesothelioma: facts, myths, and hypotheses","volume":"227","author":"Yang","year":"2012","journal-title":"J Cell Physiol"},{"key":"2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1179\/2049396712Y.0000000016","article-title":"Mesothelioma incidence in 50 states and the District of Columbia, United States, 2003-2008","volume":"19","author":"Eheman","year":"2013","journal-title":"Int J Occup Environ Health"},{"key":"3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/(SICI)1097-4644(20000201)76:2<189::AID-JCB3>3.0.CO;2-J","article-title":"Simian virus 40 and human tumors: It is time to study mechanisms","volume":"76","author":"Carbone","year":"1999","journal-title":"J Cell Biochem"},{"key":"4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3816\/CLC.2003.n.031","article-title":"Molecular pathogenesis of malignant mesothelioma and its relationship to simian virus 40","volume":"5","author":"Carbone","year":"2003","journal-title":"Clin Lung Cancer"},{"key":"5","doi-asserted-by":"crossref","first-page":"470S","DOI":"10.1378\/chest.116.suppl_3.470S","article-title":"Simian virus 40 is present in most United States human mesotheliomas, but it is rarely present in non-Hodgkin's lymphoma","volume":"116","author":"Fisher","year":"1999","journal-title":"Chest"},{"key":"6","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1073\/pnas.0808816106","article-title":"Activated TNF-alpha\/NF-kappaB signaling via down-regulation of Fas-associated factor 1 in asbestos-induced mesotheliomas from Arf knockout mice","volume":"106","author":"Testa","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1749-6632.2010.05554.x","article-title":"Inflammation precedes the development of human malignant mesotheliomas in a SCID mouse xenograft model","volume":"1203","author":"Mossman","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"8","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline BAP1 mutations predispose to malignant mesothelioma","volume":"43","author":"Powers","year":"2011","journal-title":"Nat Genet"},{"key":"9","article-title":"Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma","author":"Carbone","year":"2015","journal-title":"Oncogene"},{"key":"10","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1158\/0008-5472.CAN-14-1008","article-title":"Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma","volume":"75","author":"Pass","year":"2015","journal-title":"Cancer Res"},{"key":"11","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/JTO.0000000000000471","article-title":"High Incidence of Somatic BAP1 alterations in sporadic malignant mesothelioma","volume":"10","author":"Gaudino","year":"2015","journal-title":"J Thorac Oncol"},{"key":"12","doi-asserted-by":"crossref","first-page":"13432","DOI":"10.1073\/pnas.1612074113","article-title":"High-density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesothelioma","volume":"113","author":"Tanji","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"13","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-42740-9","article-title":"HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients","author":"Yang","year":"2016","journal-title":"Clin Cancer Res"},{"key":"14","doi-asserted-by":"crossref","first-page":"e46091","DOI":"10.1371\/journal.pone.0046091","article-title":"Early detection of malignant pleural mesothelioma in asbestos-exposed individuals with a noninvasive proteomics-based surveillance tool","volume":"7","author":"Pass","year":"2012","journal-title":"PLoS One"},{"key":"15","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.1128\/MCB.19.8.5237","article-title":"Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins","volume":"19","author":"Bustin","year":"1999","journal-title":"Mol Cell Biol"},{"key":"16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/embo-reports\/kvd030","article-title":"Upwardly mobile proteins. Workshop: the role of HMG proteins in chromatin structure, gene expression and neoplasia","volume":"1","author":"Beltrame","year":"2000","journal-title":"EMBO Rep"},{"key":"17","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1038\/onc.2010.261","article-title":"HMGB1 release and redox regulates autophagy and apoptosis in cancer cells","volume":"29","author":"Lotze","year":"2010","journal-title":"Oncogene"},{"key":"18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature00858","article-title":"Release of chromatin protein HMGB1 by necrotic cells triggers inflammation","volume":"418","author":"Bianchi","year":"2002","journal-title":"Nature"},{"key":"19","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.285.5425.248","article-title":"HMG-1 as a late mediator of endotoxin lethality in mice","volume":"285","author":"Abraham","year":"1999","journal-title":"Science"},{"key":"20","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1038\/labinvest.2009.47","article-title":"Non-histone nuclear factor HMGB1 is phosphorylated and secreted in colon cancers","volume":"89","author":"Kim","year":"2009","journal-title":"Lab Invest"},{"key":"21","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1158\/0008-5472.CAN-11-3481","article-title":"Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma","volume":"72","author":"Yang","year":"2012","journal-title":"Cancer Res"},{"key":"22","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.it.2012.10.005","article-title":"High-mobility group box family of proteins: ligand and sensor for innate immunity","volume":"33","author":"Taniguchi","year":"2012","journal-title":"Trends Immunol"},{"key":"23","doi-asserted-by":"crossref","first-page":"12611","DOI":"10.1073\/pnas.1006542107","article-title":"Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation","volume":"107","author":"Carbone","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"24","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1158\/1078-0432.CCR-06-1953","article-title":"Masquerader: high mobility group box-1 and cancer","volume":"13","author":"Lotze","year":"2007","journal-title":"Clin Cancer Res"},{"key":"25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bbagrm.2009.11.014","article-title":"High-mobility group box 1 and cancer","volume":"1799","author":"Lotze","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"26","doi-asserted-by":"crossref","first-page":"12351","DOI":"10.1073\/pnas.192222999","article-title":"Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation","volume":"99","author":"Tracey","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"27","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/00003246-200108000-00003","article-title":"Ringer's ethyl pyruvate solution ameliorates ischemia\/reperfusion-induced intestinal mucosal injury in rats","volume":"29","author":"Fink","year":"2001","journal-title":"Crit Care Med"},{"key":"28","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bcp.2010.03.007","article-title":"The biochemical basis for the anti-inflammatory and cytoprotective actions of ethyl pyruvate and related compounds","volume":"80","author":"Fink","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"29","doi-asserted-by":"crossref","first-page":"G212","DOI":"10.1152\/ajpgi.00022.2002","article-title":"Ethyl pyruvate modulates inflammatory gene expression in mice subjected to hemorrhagic shock","volume":"283","author":"Fink","year":"2002","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"30","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1097\/01.CCM.0000130835.65462.06","article-title":"Ethyl pyruvate ameliorates distant organ injury in a murine model of acute necrotizing pancreatitis","volume":"32","author":"Fink","year":"2004","journal-title":"Critical Care Medicine"},{"key":"31","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1161\/01.STR.0000181779.83472.35","article-title":"Inhibition of the cerebral ischemic injury by ethyl pyruvate with a wide therapeutic window","volume":"36","author":"Lee","year":"2005","journal-title":"Stroke"},{"key":"32","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1177\/039463201202500413","article-title":"Ethyl pyruvate administration suppresses growth and invasion of gallbladder cancer cells via downregulation of HMGB1-RAGE axis","volume":"25","author":"et","year":"2012","journal-title":"Int J Immunopathol Pharmacol"},{"key":"33","first-page":"187","article-title":"Ethyl pyruvate induces necrosis-to-apoptosis switch and inhibits high mobility group box protein 1 release in A549 lung adenocarcinoma cells","volume":"20","author":"Han","year":"2007","journal-title":"Int J Mol Med"},{"key":"34","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1189\/jlb.0908578","article-title":"Ethyl pyruvate administration inhibits hepatic tumor growth","volume":"86","author":"de_Vera","year":"2009","journal-title":"J Leukoc Biol"},{"key":"35","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1158\/0008-5472.CAN-09-3613","article-title":"Immunotherapeutic suppression of indoleamine 2,3-dioxygenase and tumor growth with ethyl pyruvate","volume":"70","author":"Prendergast","year":"2010","journal-title":"Cancer Res"},{"key":"36","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.4049\/jimmunol.0903131","article-title":"Inhibitor of NF-kappa B kinases alpha and beta are both essential for high mobility group box 1-mediated chemotaxis [corrected]","volume":"184","author":"et","year":"2010","journal-title":"J Immunol"},{"key":"37","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s10753-011-9325-5","article-title":"HMGB1 increases permeability of the endothelial cell monolayer via RAGE, Src family tyrosine kinase pathways","volume":"35","author":"Tang","year":"2012","journal-title":"Inflammation"},{"key":"38","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1146\/annurev.immunol.021908.132603","article-title":"HMGB1 and RAGE in inflammation and cancer","volume":"28","author":"Coyle","year":"2010","journal-title":"Annu Rev Immunol"},{"key":"39","doi-asserted-by":"crossref","first-page":"10397","DOI":"10.1073\/pnas.0604008103","article-title":"TNF-alpha inhibits asbestos-induced cytotoxicity via a NF-kappaB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis","volume":"103","author":"Carbone","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"40","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.bbrc.2013.12.064","article-title":"Ethyl pyruvate inhibits proliferation and induces apoptosis of hepatocellular carcinoma via regulation of the HMGB1-RAGE, AKT pathways","volume":"443","author":"et","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"41","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s10517-013-2252-8","article-title":"Immunomodulating effect of ethyl pyruvate on nonsyngenic transplanted tumor in mice","volume":"155","author":"Popova","year":"2013","journal-title":"Bull Exp Biol Med"},{"key":"42","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.canlet.2010.12.024","article-title":"Ethyl pyruvate, an anti-inflammatory agent, inhibits tumor angiogenesis through inhibition of the NF-kappaB signaling pathway","volume":"303","author":"Kim","year":"2011","journal-title":"Cancer Lett"},{"key":"43","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1053\/j.jvca.2008.08.005","article-title":"A phase II multicenter double-blind placebo-controlled study of ethyl pyruvate in high-risk patients undergoing cardiac surgery with cardiopulmonary bypass","volume":"23","author":"Fink","year":"2009","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"44","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/02652038409385855","article-title":"Mutagenic investigation of flavourings: dimethyl succinate, ethyl pyruvate and aconitic acid are negative in the Salmonella\/mammalian-microsome test","volume":"1","author":"Jensen","year":"1984","journal-title":"Food Addit Contam"},{"key":"45","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1080\/13102818.2014.942489","article-title":"Protective effects of ethyl pyruvate in cisplatin-induced nephrotoxicity","volume":"28","author":"Erdinc","year":"2014","journal-title":"Biotechnol Biotechnol Equip"},{"key":"46","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/0003-4975(94)90090-6","article-title":"Successful adenovirus-mediated gene transfer in an in vivo model of human malignant mesothelioma","volume":"57","author":"Albelda","year":"1994","journal-title":"Ann Thorac Surg"},{"key":"47","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0003-4975(95)00045-M","article-title":"Characteristics of nine newly derived mesothelioma cell lines","volume":"59","author":"Matthews","year":"1995","journal-title":"Ann Thorac Surg"},{"key":"48","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1158\/1078-0432.CCR-07-1388","article-title":"Imatinib mesylate enhances therapeutic effects of gemcitabine in human malignant mesothelioma xenografts","volume":"14","author":"Gaudino","year":"2008","journal-title":"Clin Cancer Res"},{"key":"49","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1038\/sj.onc.1201375","article-title":"Simian virus 40, poliovaccines and human tumors: a review of recent developments","volume":"15","author":"Pass","year":"1997","journal-title":"Oncogene"},{"key":"50","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.ajpath.2013.07.029","article-title":"Continuous exposure to chrysotile asbestos can cause transformation of human mesothelial cells via HMGB1 and TNF-alpha signaling","volume":"183","author":"et","year":"2013","journal-title":"Am J Pathol"},{"key":"51","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/10937404.2016.1195321","article-title":"Investigating palygorskite's role in the development of mesothelioma in southern Nevada: Insights into fiber-induced carcinogenicity","volume":"19","author":"et","year":"2016","journal-title":"J Toxicol Environ Health B Crit Rev"},{"key":"52","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1177\/1947601911412375","article-title":"Ranpirnase Interferes with NF-kappaB Pathway and MMP9 Activity, Inhibiting Malignant Mesothelioma Cell Invasiveness and Xenograft Growth","volume":"2","author":"Yang","year":"2011","journal-title":"Genes Cancer"},{"key":"53","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1465-9921-10-91","article-title":"Ethyl pyruvate reduces mortality in an endotoxin-induced severe acute lung injury mouse model","volume":"10","author":"Dong","year":"2009","journal-title":"Respir Res"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.15152","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T18:07:17Z","timestamp":1589134037000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.15152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,7]]},"references-count":53,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2017,4,4]]}},"alternative-id":["15152","28186988"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.15152","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,7]]}}}